Belgium vs Eastern Mediterranean (WHO region): Hypertension: effective treatment coverage (controlled hypertension)
Belgium
40.0%
in 2019
Eastern Mediterranean (WHO region)
14.7%
in 2019
Belgium rank
9th
Eastern Mediterranean (WHO region) rank
10th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Belgium
- Eastern Mediterranean (WHO region)
How they compare
Belgium currently reports 40.0% against 14.7% in Eastern Mediterranean (WHO region), a difference of 25.3%.
That makes Belgium's figure about 2.7 times Eastern Mediterranean (WHO region)'s.
Across all 30 years both countries report, Belgium has been ahead every year.
Belgium ranks 9th and Eastern Mediterranean (WHO region) ranks 10th of 193 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Eastern Mediterranean (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.8% | 4.9% | 9.9% | Belgium |
| 2000s | 28.0% | 8.2% | 19.8% | Belgium |
| 2010s | 37.9% | 13.2% | 24.7% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Belgium or Eastern Mediterranean (WHO region)?
- Belgium, at 40.0% against 14.7% in Eastern Mediterranean (WHO region) as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Belgium and Eastern Mediterranean (WHO region)?
- 25.3%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Eastern Mediterranean (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do Belgium and Eastern Mediterranean (WHO region) rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Belgium ranks 9th and Eastern Mediterranean (WHO region) ranks 10th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.